Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Clinical trials with vaccines

Clinical trials with vaccines

Clinical research in humans is currently highly regulated and rigorous from an ethical, logistical and scientific point of view. At all times, the well-being of the participating subject is above the need to achieve some innovative discovery in medicine, even in times of health emergencies.
In many countries, including Panama, there is a research law for drugs, vaccines and devices that, in addition to protecting the person recruited in the trials, supervises the quality and competence of the researchers and their study sites, legislating on the entire experimental process, and protects the legal security of the sponsoring entities (Law 84, May 14, 2009). No study can be carried out in the country without having been registered with the general health department and obtained the approval of the independent bioethics committees.

After the authorization of the project, the participant must go through a meticulous informed consent process that includes knowing extensive information about the potential benefits and risks, data from previous product investigations (in vitro, animal model, previous clinical phase) and the rights or duties in case of accepting your enrollment. The decision is completely voluntary, autonomous, free and devoid of any economic incentive.

The subject can discuss consent with family, friends or professionals before signing. Once inside, the individual must comply with the follow-up visits and with the procedures described in the protocol (vaccinations, sample extractions, records of adverse events, calls or alert messages, etc.). In case of dissatisfaction or inability to adjust to the demands, the person may also choose to withdraw without this causing any kind of affectation.

The proper conduct of a research study is constantly monitored by companies specialized in data monitoring, audited by organizations in charge of quality processes and inspected by regulatory bodies (FDA, EMA, ethics committees), according to the relevance and magnitude of each project. Participants who, by chance, are in the control group, are assigned a comparator vaccine as a benefit, apart from being entitled to medical evaluations and laboratory tests that ensure optimal surveillance of their health condition.

Considerable evidence reveals that people who join clinical trials, even receiving placebo, have advantages over those who do not participate, because they receive frequent personalized attention by a professional team trained and certified in good clinical practice.

At the end of the investigation, if the evaluated product is safe and effective, it is offered free of charge to those who, by random destination, did not have it at the beginning.

Being able to participate in a scientific study is considered a basic human right. Everyone should have that option and in their own country of residence. Any of us, faced with a potentially serious illness, would travel to a place where some new and promising treatment is experienced to improve the prognosis.

Not everyone, unfortunately, has the resources to move to those research sites. Therefore, the bringing of projects to our region should be encouraged. In addition, not all therapy or vaccine behaves the same in Caucasian or Asian populations as in black, mestizo or indigenous populations.

Although the literature indicates that the majority of people who decide to join clinical trials do so for altruistic reasons (to improve the health of others and advance medical knowledge), others hope for a direct benefit or the opportunity to contact professionals trained to discuss health problems for themselves or for their family members.

No academic institution or pharmaceutical corporation risks studying its vaccine in a country that does not provide quality research, ethical rigor and publication in high-impact journals. For the studies on Covid-19, national vaccine researchers have joined in a country project, a consortium or coalition with more than 20 years of experience and trajectory in studies of national and international relevance, both in children and in adults.

Several important projects in the prevention of SARS-CoV-2 infections will soon begin, which will surely provide scientific information on the safety and efficacy of various vaccines, with diverse technological platforms. The advantages of evaluating numerous vaccines worldwide are multiple: greater accessibility, less commercial monopoly, better price and differential value for specific age and risk groups.

Vaccines are, after drinking water, the most cost-effective investment that exists in public health, not only in preventive impact and risk-benefit ratio, but also in the fight against social inequality.

Young people should review history so that they can know the figures of millions of people who died, were paralyzed or suffered serious physical consequences from multiple communicable diseases (polio, measles, rubella, tetanus, diphtheria, tuberculosis, meningitis, pneumonia, whooping cough, diarrhea, hepatitis, chickenpox, etc.) that today have been controlled or eradicated thanks to vaccination. For the few who would like to live without vaccines, this pandemic is the best example of the absence of one; now imagine the world without any.

The author, Xavier Sáez Llorens, is a doctor
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
House Republicans Move to Defund OECD Over Global Tax Dispute
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
Intel Reports Revenue Beats but Sees 81% Rise in Losses
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
CEO Resigns Amid Controversy Over Relationship with HR Executive
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
Tulsi Gabbard Unveils Evidence Alleging Political Manipulation of Intelligence During Trump Administration
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Trump Announces Coca-Cola to Shift to Cane Sugar in U.S. Production
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Air India Pilot’s Mental Health Records Under Scrutiny
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
Moonshot AI Unveils Kimi K2: A New Open-Source AI Model
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Bitcoin Reaches New Milestone of $116,000
Severe Heatwave Claims 2,300 Lives Across Europe
Declining Beer Consumption Signals Cultural Shift in Germany
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
Western Europe Records Hottest June on Record
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
China’s Central Bank Consults European Peers on Low-Rate Strategies
France Requests Airlines to Cut Flights at Paris Airports Amid Planned Air Traffic Controller Strike
Poland Implements Border Checks Amid Growing Migration Tensions
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
×